Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...

Thermo Fisher reported Q4 revenue of $11.4 billion, a 4.7% increase year over year. While the company beat analysts’ ...

Shares of Thermo Fisher Scientific Inc. TMO advanced 1.48% to $524.19 Wednesday, on what proved to be an all-around great ...

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$429.2 million in 2024 and an impressive US$969.5 million by 2030. The ...

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$429.2 million ...

FE International acted as the exclusive M&A advisor to Vidello, ensuring a seamless transaction aligned with both parties’ strategic objectives. For more information about FE International and its ...

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models ...

Thermo Fisher Scientific is a life sciences powerhouse, but its stock has struggled. TMO has fallen 15.8% from its 52-week ...

Thermo Fisher Scientific Inc. closed 16.60% short of its 52-week high of $627.88, which the company achieved on September 10th.

The global HIV diagnosis market, valued at US$2.96 billion in 2024, is forecasted to grow at a robust CAGR of 10.3%, reaching US$3.25 billion ...